Response to 'Unlikely influence of ABO blood group polymorphism on antibody response to COVID-19 mRNA vaccine against SARS-CoV-2 spike protein'.
作者信息
Bordino Valerio, Vicentini Costanza, Zotti Carla Maria
机构信息
Department of Public Health and Paediatrics, University of Turin, Turin, Italy.
出版信息
Vox Sang. 2022 Sep;117(9):1128. doi: 10.1111/vox.13340. Epub 2022 Aug 2.
Abstract
摘要
相似文献
1
Response to 'Unlikely influence of ABO blood group polymorphism on antibody response to COVID-19 mRNA vaccine against SARS-CoV-2 spike protein'.对《ABO血型多态性对COVID-19 mRNA疫苗针对SARS-CoV-2刺突蛋白抗体反应的影响不太可能》的回应
Vox Sang. 2022 Sep;117(9):1128. doi: 10.1111/vox.13340. Epub 2022 Aug 2.
2
Unlikely influence of ABO blood group polymorphism on antibody response to COVID-19 mRNA vaccine against SARS-CoV-2 spike protein.ABO血型多态性对针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白的新冠病毒mRNA疫苗抗体反应的影响不大。
Vox Sang. 2022 Sep;117(9):1126-1127. doi: 10.1111/vox.13341. Epub 2022 Aug 2.
3
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.新型冠状病毒刺突蛋白受体结合域线性表位在 COVID-19 mRNA 疫苗接种者中的高分辨率线性表位作图。
Microbiol Spectr. 2021 Dec 22;9(3):e0096521. doi: 10.1128/Spectrum.00965-21. Epub 2021 Nov 10.
4
Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination.辉瑞-BioNTech 新冠疫苗接种 6 个月后针对 SARS-CoV-2 关注变异株的抗体反应
Microbiol Spectr. 2022 Apr 27;10(2):e0225221. doi: 10.1128/spectrum.02252-21. Epub 2022 Mar 9.
5
Nucleocapsid as a next-generation COVID-19 vaccine candidate.核衣壳作为下一代 COVID-19 疫苗候选物。
Int J Infect Dis. 2022 Sep;122:529-530. doi: 10.1016/j.ijid.2022.06.046. Epub 2022 Jul 3.
6
A bivalent vaccine containing D614G and BA.1 spike trimer proteins or a BA.1 spike trimer protein booster shows broad neutralizing immunity.含有 D614G 和 BA.1 刺突三聚体蛋白的二价疫苗或 BA.1 刺突三聚体蛋白加强针可产生广泛的中和免疫。
J Med Virol. 2022 Sep;94(9):4287-4293. doi: 10.1002/jmv.27885. Epub 2022 Jun 2.
7
Antibody responses to the SARS-CoV-2 vaccines in hemodialysis patients: Is inactivated vaccine effective?血液透析患者对 SARS-CoV-2 疫苗的抗体反应：灭活疫苗有效吗？
Ther Apher Dial. 2022 Aug;26(4):769-774. doi: 10.1111/1744-9987.13752. Epub 2021 Nov 16.
8
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients.mRNA SARS-CoV-2 疫苗的第三剂加强了骨髓纤维化患者的刺突特异性抗体和记忆 B 细胞反应。
Front Immunol. 2022 Sep 29;13:1017863. doi: 10.3389/fimmu.2022.1017863. eCollection 2022.
9
Comparison of Immune Responses Elicited by SARS-CoV-2 mRNA and Recombinant Protein Vaccine Candidates.SARS-CoV-2 mRNA 和重组蛋白候选疫苗引起的免疫反应比较。
Front Immunol. 2022 May 19;13:906457. doi: 10.3389/fimmu.2022.906457. eCollection 2022.
10
Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2.细菌介导的基于复制子的 mRNA 疫苗候选物经口腔递送可预防原始和德尔塔变异 SARS-CoV-2。
Mol Ther. 2022 May 4;30(5):1926-1940. doi: 10.1016/j.ymthe.2022.01.042. Epub 2022 Feb 3.
本文引用的文献
1
Unlikely influence of ABO blood group polymorphism on antibody response to COVID-19 mRNA vaccine against SARS-CoV-2 spike protein.ABO血型多态性对针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白的新冠病毒mRNA疫苗抗体反应的影响不大。
Vox Sang. 2022 Sep;117(9):1126-1127. doi: 10.1111/vox.13341. Epub 2022 Aug 2.
2
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine is not influenced by AB0 blood group in subjects with transfusion-dependent thalassemia.对依赖输血的地中海贫血患者，AB0 血型对 BNT162b2 新型冠状病毒疫苗 mRNA 抗体反应无影响。
Acta Biomed. 2022 May 11;93(2):e2022134. doi: 10.23750/abm.v93i2.12819.
3
Does ABO blood group influence antibody response to SARS-CoV-2 vaccination?ABO血型会影响对SARS-CoV-2疫苗接种的抗体反应吗？
Vox Sang. 2022 May;117(5):754-755. doi: 10.1111/vox.13241. Epub 2021 Dec 28.
4
Blood group ABO polymorphism inhibits SARS-CoV-2 infection and affects COVID-19 progression.ABO血型多态性可抑制新型冠状病毒感染并影响新冠肺炎病情进展。
Vox Sang. 2021 Jan;116(1):15-17. doi: 10.1111/vox.13004. Epub 2020 Sep 23.
5
Implications of AB0 blood group in hypertensive patients with covid-19.AB0 血型在合并 COVID-19 的高血压患者中的意义。
BMC Cardiovasc Disord. 2020 Aug 14;20(1):373. doi: 10.1186/s12872-020-01658-z.
Zotero 插件